D.A. Davidson & Co. Dexcom Inc Transaction History

D.A. Davidson & Co.

$12 Billion
Q3 2024

A detailed history of D.A. Davidson & Co. transactions in Dexcom Inc stock. As of the latest transaction made, D.A. Davidson & Co. holds 32,578 shares of DXCM stock, worth $2.61 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

32,578

Previous 26,609 22.43%

Holding current value

$2.61 Million

Previous $3.02 Million 27.62%

% of portfolio

0.02%

Previous 0.03%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$64.0 - $116.06 $382,016 - $692,762	5,969 Added 22.43%	32,578 $2.18 Million
Q2 2024 Jul 31, 2024	SELL	$110.31 - $140.45 $979,111 - $1.25 Million	-8,876 Reduced 25.01%	26,609 $3.02 Million
Q1 2024 May 13, 2024	BUY	$114.22 - $140.1 $1,142 - $1,401	10 Added 0.03%	35,485 $4.92 Million
Q4 2023 Feb 09, 2024	BUY	$75.49 - $124.16 $35,102 - $57,734	465 Added 1.33%	35,475 $4.4 Million
Q3 2023 Nov 08, 2023	BUY	$86.06 - $137.93 $811,717 - $1.3 Million	9,432 Added 36.88%	35,010 $3.27 Million
Q2 2023 Aug 10, 2023	SELL	$112.47 - $130.98 $521,973 - $607,878	-4,641 Reduced 15.36%	25,578 $3.29 Million
Q1 2023 Apr 25, 2023	BUY	$104.0 - $122.92 $13,000 - $15,365	125 Added 0.42%	30,219 $3.51 Million
Q4 2022 Feb 03, 2023	SELL	$84.98 - $122.67 $193,414 - $279,196	-2,276 Reduced 7.03%	30,094 $3.41 Million
Q3 2022 Nov 07, 2022	SELL	$76.35 - $94.18 $98,644 - $121,680	-1,292 Reduced 3.84%	32,370 $2.61 Million
Q2 2022 Jul 28, 2022	BUY	$67.99 - $132.89 $1.75 Million - $3.42 Million	25,756 Added 325.78%	33,662 $2.51 Million
Q1 2022 May 12, 2022	SELL	$94.08 - $130.2 $17,592 - $24,347	-187 Reduced 2.31%	7,906 $4.05 Million
Q4 2021 Jan 31, 2022	BUY	$129.87 - $162.82 $5,584 - $7,001	43 Added 0.53%	8,093 $4.35 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $33,613 - $45,101	-315 Reduced 3.77%	8,050 $4.4 Million
Q2 2021 Aug 10, 2021	BUY	$80.99 - $107.93 $62,767 - $83,645	775 Added 10.21%	8,365 $3.57 Million
Q1 2021 May 07, 2021	BUY	$84.79 - $104.74 $500,600 - $618,384	5,904 Added 350.18%	7,590 $2.73 Million
Q4 2020 Feb 10, 2021	BUY	$78.0 - $104.5 $32,526 - $43,576	417 Added 32.86%	1,686 $623,000
Q3 2020 Nov 02, 2020	BUY	$95.51 - $112.95 $9,742 - $11,520	102 Added 8.74%	1,269 $523,000
Q2 2020 Aug 10, 2020	SELL	$62.68 - $105.34 $254,668 - $427,996	-4,063 Reduced 77.69%	1,167 $473,000
Q1 2020 May 05, 2020	BUY	$47.79 - $75.63 $39,952 - $63,226	836 Added 19.03%	5,230 $1.41 Million
Q4 2019 Feb 14, 2020	SELL	$36.62 - $57.29 $22,997 - $35,978	-628 Reduced 12.5%	4,394 $961,000
Q3 2019 Nov 05, 2019	SELL	$35.53 - $43.8 $1,598 - $1,970	-45 Reduced 0.89%	5,022 $749,000
Q2 2019 Aug 13, 2019	BUY	$27.84 - $38.92 $5,568 - $7,784	200 Added 4.11%	5,067 $759,000
Q1 2019 May 13, 2019	SELL	$28.07 - $38.18 $21,754 - $29,589	-775 Reduced 13.74%	4,867 $580,000
Q4 2018 Jan 29, 2019	BUY	$26.99 - $37.37 $56,975 - $78,888	2,111 Added 59.78%	5,642 $676,000
Q3 2018 Nov 13, 2018	SELL	$23.35 - $36.72 $4,646 - $7,307	-199 Reduced 5.34%	3,531 $505,000
Q2 2018 Aug 02, 2018	BUY	$17.54 - $25.22 $877 - $1,261	50 Added 1.36%	3,730 $354,000
Q1 2018 May 04, 2018	BUY	$13.06 - $18.54 $653 - $927	50 Added 1.38%	3,680 $273,000
Q4 2017 Feb 08, 2018	BUY	$11.12 - $15.38 $40,365 - $55,829	3,630 New	3,630 $208,000
Q3 2017 Nov 08, 2017	SELL	$11.36 - $18.98 $36,920 - $61,685	-3,250 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	3,250	3,250 $0

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.

Account